Table 1.

Single-nucleotide polymorphisms included in the analysis, and results of analysis of covariance with Scale for the Assessment of Negative Symptoms scores

SNP	Chromosome	Position	Gene	Risk allele	Reference	F statistic	p value
rs4765913	12	2310730	CACNA1C	A	Perlis et al.19	0.111	0.74
rs10896135	11	66783531	C11orf80	G		0.869	0.35
rs10994336	10	60420054	ANK3	T		2.061	0.15
rs10994397	10	60519366	ANK3	T		3.008	0.09
rs12576775	11	79366149	TENM4	G		1.162	0.28
rs1006737	12	2236129	CACNA1C	A		0.054	0.82
rs1938526	10	60540625	ANK3	G	Zhang et al.20	0.49	0.49
rs736408	3	52801338	ITIH3	C	Li et al.21	2.491	0.12
rs2070615	12	48824388	CACNB3	G		6.202	0.014
rs2175420	11	79412839	TENM4	T		2.354	0.13
rs2176528	2	1.94E+08	N/A	G		1.388	0.24
rs3774609	3	53798876	CACNA1D	T		0.064	0.80
rs3845817	2	65531391	N/A	T		1.67	0.20
rs4660531	1	41374150	FOXO6	T		5.854	0.017
rs6746896	2	96745212	N/A	G		0.53	0.47
rs7296288	12	49086185	N/A	C		0.157	0.69
rs7578035	2	98766429	N/A	G		1.363	0.25
rs9804190	10	60080073	ANK3	C		0.015	0.90
rs11168751	12	48825355	CACNB3	G		0.473	0.49
rs9371601	6	1.52E+08	SYNE1	T		0.118	0.73
rs11030101	11	27659197	BDNF, BDNF-AS	T	Xu et al.22	0.424	0.52

N/A = not applicable; SNP = single-nucleotide polymorphism.